| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5287932
Max Phase: Preclinical
Molecular Formula: C20H16N4O5
Molecular Weight: 392.37
Associated Items:
Representations
Canonical SMILES: COc1ccn2c(-c3ccc(NC(=O)c4ccc([N+](=O)[O-])o4)c(C)c3)cnc2c1
Standard InChI: InChI=1S/C20H16N4O5/c1-12-9-13(16-11-21-18-10-14(28-2)7-8-23(16)18)3-4-15(12)22-20(25)17-5-6-19(29-17)24(26)27/h3-11H,1-2H3,(H,22,25)
Standard InChI Key: OMQKLMVWHFHOEU-UHFFFAOYSA-N
Associated Targets(Human)
AGS (1999 Activities)
MGC-803 (6426 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
STAT3 Tchem Signal transducer and activator of transcription 3 (3313 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 392.37 | Molecular Weight (Monoisotopic): 392.1121 | AlogP: 4.07 | #Rotatable Bonds: 5 |
| Polar Surface Area: 111.91 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 12.66 | CX Basic pKa: 5.66 | CX LogP: 2.86 | CX LogD: 2.86 |
| Aromatic Rings: 4 | Heavy Atoms: 29 | QED Weighted: 0.40 | Np Likeness Score: -1.84 |
References
| 1. Li H, Ouyang S, Zhang Y, Peng K, Fang W, Liu Z, Wang CY, Zhang X, Wang Y.. (2022) Structural optimization of Imidazo[1, 2-a]pyridine derivatives for the treatment of gastric cancer via STAT3 signaling pathway., 244 [PMID:36283181] [10.1016/j.ejmech.2022.114858] |
Source
Source(1):